ACURATE neo falls short against SAPIEN 3 for severe aortic stenosis

SAN FRANCISCO – The differences between the two TAVR devices were mainly driven by moderate or severe paravalvular regurgitation and stage 2-3 acute kidney injury.

Read the full article here

Related Articles